non-hirudineans only
仅限非蛭形动物
studying non-hirudineans
研究非蛭形动物
identifying non-hirudineans
识别非蛭形动物
analyzing non-hirudineans
分析非蛭形动物
excluding non-hirudineans
排除非蛭形动物
presence of non-hirudineans
非蛭形动物的存在
detecting non-hirudineans
检测非蛭形动物
surveying non-hirudineans
调查非蛭形动物
classifying non-hirudineans
分类非蛭形动物
researchers are investigating the efficacy of non-hirudineans in treating thrombosis.
研究人员正在调查非泥足类的有效性，用于治疗血栓。
the study focused on the coagulation properties of non-hirudineans compared to hirudin.
该研究侧重于将非泥足类与泥足类的凝血特性进行比较。
non-hirudineans offer a potential alternative for patients with heparin-induced thrombocytopenia.
非泥足类为有肝素诱导性血小板减少症的患者提供了一种潜在的替代方案。
several synthetic non-hirudineans have been developed for clinical use.
已经开发出几种用于临床使用的合成非泥足类。
the binding affinity of non-hirudineans to thrombin varied significantly.
非泥足类与凝血酶的结合亲和力差异很大。
pharmacokinetic profiles of non-hirudineans are being carefully evaluated.
非泥足类的药代动力学特征正在被仔细评估。
compared to traditional anticoagulants, non-hirudineans showed a different mechanism of action.
与传统的抗凝剂相比，非泥足类显示出不同的作用机制。
the development of novel non-hirudineans remains an active area of research.
新型非泥足类的开发仍然是一个活跃的研究领域。
clinical trials are assessing the safety and efficacy of new non-hirudineans.
临床试验正在评估新非泥足类的安全性和有效性。
the cost-effectiveness of non-hirudineans is a key consideration for healthcare providers.
医疗保健提供者需要考虑非泥足类的成本效益。
understanding the structure-activity relationship of non-hirudineans is crucial for drug design.
理解非泥足类的构效关系对于药物设计至关重要。
non-hirudineans only
仅限非蛭形动物
studying non-hirudineans
研究非蛭形动物
identifying non-hirudineans
识别非蛭形动物
analyzing non-hirudineans
分析非蛭形动物
excluding non-hirudineans
排除非蛭形动物
presence of non-hirudineans
非蛭形动物的存在
detecting non-hirudineans
检测非蛭形动物
surveying non-hirudineans
调查非蛭形动物
classifying non-hirudineans
分类非蛭形动物
researchers are investigating the efficacy of non-hirudineans in treating thrombosis.
研究人员正在调查非泥足类的有效性，用于治疗血栓。
the study focused on the coagulation properties of non-hirudineans compared to hirudin.
该研究侧重于将非泥足类与泥足类的凝血特性进行比较。
non-hirudineans offer a potential alternative for patients with heparin-induced thrombocytopenia.
非泥足类为有肝素诱导性血小板减少症的患者提供了一种潜在的替代方案。
several synthetic non-hirudineans have been developed for clinical use.
已经开发出几种用于临床使用的合成非泥足类。
the binding affinity of non-hirudineans to thrombin varied significantly.
非泥足类与凝血酶的结合亲和力差异很大。
pharmacokinetic profiles of non-hirudineans are being carefully evaluated.
非泥足类的药代动力学特征正在被仔细评估。
compared to traditional anticoagulants, non-hirudineans showed a different mechanism of action.
与传统的抗凝剂相比，非泥足类显示出不同的作用机制。
the development of novel non-hirudineans remains an active area of research.
新型非泥足类的开发仍然是一个活跃的研究领域。
clinical trials are assessing the safety and efficacy of new non-hirudineans.
临床试验正在评估新非泥足类的安全性和有效性。
the cost-effectiveness of non-hirudineans is a key consideration for healthcare providers.
医疗保健提供者需要考虑非泥足类的成本效益。
understanding the structure-activity relationship of non-hirudineans is crucial for drug design.
理解非泥足类的构效关系对于药物设计至关重要。
探索常用高频词汇